(IT-NEWSWIRE.COM, August 10, 2018 ) Browse 124 market data tables and 46 figures spread through 172 pages and in-depth TOC on “Cell Isolation/Cell Separation Market”
The global cell isolation market is expected to reach USD 7.89 Billion by 2021 from USD 3.57 Billion in 2016 at a CAGR of 17.2% from 2016 to 2021. The major factors driving the growth of this market are the increasing government funding for cell based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, growing focus on personalized medicine, and expanding biotechnology and biopharmaceutical industries.
The report segments this market on the basis of product, cell type, technique, application, and end user. On the basis of product, the cell isolation market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the market during the forecast period. The large share of this segment is attributed to increasing investments by companies to develop advanced products, increasing number of regulatory approvals, and rising government initiatives for enhancing cell-based research.
Based on cell type, the cell isolation market is segmented into human cells and animal cells. The human cells segment is projected to witness the largest growth in this market due to technological advancements; increasing focus on human stem cell isolation; and wide usage of isolated differentiated human cells in research, academics, therapeutics, and biopharmaceutical & biotechnology industries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsample.asp?id=103931479
Based on technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is projected to witness the largest growth during the forecast period primarily due to the wide usage of this technique among end users. This system is used on a large scale by biotechnology and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia for manufacturing vaccines, enzymes, and antibodies.
Based on application, the cell isolation market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics. The biomolecule isolation segment is projected to witness the highest growth rate in this market primarily due to increasing company investments to develop new biopharmaceutical products.
Based on region, the global cell isolation market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The Asian market is expected to grow at the highest CAGR during the forecast period. Factors such as increasing interest in emerging markets, government support, and high prevalence of diseases are driving the growth of this market.
The key players in the cell isolation market include by Beckman Coulter, Inc. (U.S.), BD Biosciences (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Bio-Rad Laboratories Inc. (U.S.).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
Mr. Shelly Singh